Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Foto på Mattias Ohlsson

Mattias Ohlsson

Professor

Foto på Mattias Ohlsson

Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia

Författare

  • Bob Olsson
  • Joakim Hertze
  • Mattias Ohlsson
  • Katarina Nägga
  • Kina Hoglund
  • Hans Basun
  • Peter Annas
  • Lars Lannfelt
  • Niels Andreasen
  • Lennart Minthon
  • Henrik Zetterberg
  • Kaj Blennow
  • Oskar Hansson
Visa allt

Summary, in English

Heart fatty acid binding protein (HFABP) is expressed in the brain and is elevated in cerebrospinal fluid (CSF) from patients with several forms of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease with dementia, Lewy body dementia, vascular dementia (VaD), and Creutzfeldt-Jakob disease. However, whether HFABP in CSF is a stable biomarker or if it can help predict conversion from mild cognitive impairment (MCI) to AD or VaD has not been well studied. To address the role of HFABP in neurodegeneration, we analyzed CSF levels of HFABP in 96 AD patients and 65 controls and also in 170 patients with MCI with an average follow up time of 5.7 years. For the stability analysis, two CSF samples were collected from 52 AD patients with a six month interval in between. HFABP levels in CSF were very stable over the six month period (r = 0.93, p < 0.001). Furthermore, the CSF levels of HFABP were significantly elevated in AD compared with controls after adjustments for age and gender (p < 0.001). They were also elevated in the patients with MCI that subsequently converted to AD or VaD compared with those that remained stable (p < 0.001 and p < 0.05, respectively). However, ROC curve analysis showed that HFABP had lesser predictive value in determining conversion from MCI to AD and VaD than A beta(42), t-tau, and p-tau. In conclusion, HFABP seems to be a stable CSF biomarker that reflects neuronal cell death in several neurodegenerative disorders, including early stages of AD and VaD.

Avdelning/ar

  • Klinisk minnesforskning
  • Beräkningsbiologi och biologisk fysik - Genomgår omorganisation
  • MultiPark: Multidisciplinary research focused on Parkinson´s disease

Publiceringsår

2013

Språk

Engelska

Sidor

673-679

Publikation/Tidskrift/Serie

Journal of Alzheimer's Disease

Volym

34

Issue

3

Dokumenttyp

Artikel i tidskrift

Förlag

IOS Press

Ämne

  • Neurology

Nyckelord

  • Alzheimer's disease
  • biomarker
  • cerebrospinal fluid
  • dementia
  • HFABP
  • vascular dementia

Status

Published

Forskningsgrupp

  • Clinical Memory Research

ISBN/ISSN/Övrigt

  • ISSN: 1387-2877